The_DT
AP-1_NN
site_NN
at_IN
-150_CD
bp_NN
,_,
but_CC
not_RB
the_DT
NF-kappa_NN
B_NN
site_NN
,_,
is_VBZ
likely_JJ
to_TO
represent_VB
the_DT
major_JJ
target_NN
of_IN
protein_NN
kinase_NN
C_NN
in_IN
the_DT
interleukin_NN
2_CD
promoter_NN
._.

Stimulation_NN
of_IN
T_NN
cells_NNS
with_IN
antigen_NN
results_VBZ
in_IN
activation_NN
of_IN
several_JJ
kinases_NNS
,_,
including_VBG
protein_NN
kinase_NN
C_NN
-LRB-_-LRB-
PKC_NN
-RRB-_-RRB-
,_,
that_WDT
may_MD
mediate_VB
the_DT
later_JJR
induction_NN
of_IN
activation-related_JJ
genes_NNS
._.

We_PRP
have_VBP
examined_VBN
the_DT
potential_JJ
role_NN
of_IN
PKC_NN
in_IN
induction_NN
of_IN
the_DT
interleukin_NN
2_CD
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
gene_NN
in_IN
T_NN
cells_NNS
stimulated_VBN
through_IN
the_DT
T_NN
cell_NN
receptor\/CD3_NN
complex_NN
._.

We_PRP
have_VBP
previously_RB
shown_VBN
that_IN
prolonged_JJ
treatment_NN
of_IN
the_DT
untransformed_JJ
T_NN
cell_NN
clone_NN
Ar-5_NN
with_IN
phorbol_NN
esters_NNS
results_VBZ
in_IN
downmodulation_NN
of_IN
the_DT
alpha_NN
and_CC
beta_NN
isozymes_NNS
of_IN
PKC_NN
,_,
and_CC
abrogates_VBZ
induction_NN
of_IN
IL-2_NN
mRNA_NN
and_CC
protein_NN
._.

Here_RB
we_PRP
show_VBP
that_IN
phorbol_NN
ester_NN
treatment_NN
also_RB
abolishes_VBZ
induction_NN
of_IN
chloramphenicol_NN
acetyltransferase_NN
activity_NN
in_IN
Ar-5_NN
cells_NNS
transfected_VBN
with_IN
a_DT
plasmid_NN
containing_VBG
the_DT
IL-2_NN
promoter_NN
linked_VBN
to_TO
this_DT
reporter_NN
gene_NN
._.

The_DT
IL-2_NN
promoter_NN
contains_VBZ
binding_VBG
sites_NNS
for_IN
nuclear_JJ
factors_NNS
including_VBG
NFAT-1_NN
,_,
Oct_NN
,_,
NF-kappa_NN
B_NN
,_,
and_CC
AP-1_NN
,_,
which_WDT
are_VBP
all_DT
potentially_RB
sensitive_JJ
to_TO
activation_NN
of_IN
PKC_NN
._.

We_PRP
show_VBP
that_IN
induction_NN
of_IN
a_DT
trimer_NN
of_IN
the_DT
NFAT_NN
and_CC
Oct_NN
sites_NNS
is_VBZ
not_RB
sensitive_JJ
to_TO
phorbol_NN
ester_NN
treatment_NN
,_,
and_CC
that_IN
mutations_NNS
in_IN
the_DT
NF-kappa_NN
B_NN
site_NN
have_VBP
no_DT
effect_NN
on_IN
inducibility_NN
of_IN
the_DT
IL-2_NN
promoter_NN
._.

In_IN
contrast_NN
,_,
mutations_NNS
in_IN
the_DT
AP-1_NN
site_NN
located_JJ
at_IN
-150_CD
bp_NN
almost_RB
completely_RB
abrogate_VBP
induction_NN
of_IN
the_DT
IL-2_NN
promoter_NN
,_,
and_CC
appearance_NN
of_IN
an_DT
inducible_JJ
nuclear_JJ
factor_NN
binding_NN
to_TO
this_DT
site_NN
is_VBZ
sensitive_JJ
to_TO
PKC_NN
depletion_NN
._.

Moreover_RB
,_,
cotransfections_NNS
with_IN
c-fos_NN
and_CC
c-jun_NN
expression_NN
plasmids_NNS
markedly_RB
enhance_VBP
induction_NN
of_IN
the_DT
IL-2_NN
promoter_NN
in_IN
minimally_RB
stimulated_VBN
T_NN
cells_NNS
._.

Our_PRP$
results_NNS
indicate_VBP
that_IN
the_DT
AP-1_NN
site_NN
at_IN
-150_CD
bp_NN
represents_VBZ
a_DT
major_JJ
,_,
if_IN
not_RB
the_DT
only_JJ
,_,
site_NN
of_IN
PKC_NN
responsiveness_NN
in_IN
the_DT
IL-2_NN
promoter_NN
._.

